Lumefantrine
Antimalarial — ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
Also known as: benflumelol, benflumetol
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Lumefantrine is an ofp drug in the Antimalarial class catalogued in DrugCentral. It was first approved by the FDA in 2009. DrugCentral lists 1 molecular target, including KCNH2. Recorded indications include Falciparum malaria.
- Approval status: ofp (first approved 2009 by the FDA).
- Drug class: Antimalarial.
- Molecular targets: KCNH2 (1 listed in DrugCentral).
- Indications: Falciparum malaria.
- ATC code: P01BF01 (Artemisinin and derivatives, combinations).
- Molecular formula: C30H32Cl3NO; molecular weight 528.94 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Falciparum malaria
Contraindications (6)
- Bradycardia
- Congenital long QT syndrome
- Hypokalemia
- Hypomagnesemia
- Prolonged QT interval
- Torsades de pointes
Mechanism & targets
| Established pharmacologic class | Antimalarial |
|---|
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Potassium voltage-gated channel subfamily H member 2 | KCNH2 | unknown | IC50 5.09 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 2009-04-07 | FDA | — | NOVARTIS | Yes |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
P01BF01 | ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTIPROTOZOALS › ANTIMALARIALS › Artemisinin and derivatives, combinations |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Lumefantrine is on its molecule page.
| Molecular formula | C30H32Cl3NO |
|---|---|
| Molecular weight | 528.94 g/mol |
| CAS number | 82186-77-4 |
| InChIKey | DYLGFOYVTXJFJP-MYYYXRDXSA-N |
| PubChem CID | 6437380 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Lumefantrine used for?
DrugCentral lists the following indications for Lumefantrine: Falciparum malaria.
How does Lumefantrine work?
Its molecular targets in DrugCentral include KCNH2.
When was Lumefantrine first approved?
Lumefantrine was first approved by the FDA in 2009.
What drug class does Lumefantrine belong to?
Lumefantrine is in the Antimalarial class.
What is the chemical formula of Lumefantrine?
Lumefantrine has the molecular formula C30H32Cl3NO and a molecular weight of 528.94 g/mol.
Browse: all drugs starting with L · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1617 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL38827 — compound record and bioactivity
- PubChem CID 6437380 — chemical identifiers
- DrugBank DB06708 — drug record
- FDA UNII F38R0JR742 — substance identity
- DailyMed: FDA labels for Lumefantrine — current prescribing information (label search)
- UniProt Q12809 (KCNH2) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.